On Air Now

Listen

Listen Live Now » 94.7 FM Central Wisconsin 102.9 FM Wausau, WI

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
56° Feels Like: 56°
Wind: S 6 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Mostly Clear 47°

Tomorrow

Partly Cloudy 70°

Fri Night

Thunderstorms 62°

Alerts

Roche says Gazyvaro approved in Europe against leukemia

ZURICH (Reuters) - Roche said on Tuesday that European regulators approved its drug Gazyvaro, or obinutuzumab, for patients with chronic lymphocytic leukemia, boosting the Swiss group's line-up of new cancer treatments.

The new medicine is an improved follow-on medicine to the Swiss drugmaker's $7 billion-a-year Rituxan, or MabThera, and Roche is hoping to switch as many patients as possible to the newer product before Rituxan faces competition from cheaper copies.

The move endorses a favorable recommendation in May from the European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP), which are normally followed by the European Commission.

(Reporting By Katharina Bart)

Comments